Aves Labs Neuronal Cell Markers
30 August, 2014Aves Labs chicken-produced neural cell marker antibodies can be used along with existing mouse or rabbit antibodies in double-labelling studies. The neuronal cell markers are made against sequences that are 100% shared between mouse and human proteins, ensuring that the neural cell marker antibodies will react with a wide range of different mammalian species.
Proteintech antibodies for ciliogenesis
30 August, 2014The primary cilium acts as a sensory organelle that transfers information from the environment to the cell interior. Proteintech has over 70 antibodies recognising cilia-related proteins.
Abcam RabMAb rabbit monoclonal antibodies
12 August, 2014Rabbit monoclonal (RabMAb) antibodies offer the antigen recognition of the rabbit immune system combined with the specificity and consistency of a monoclonal, providing antibodies with good binding affinity and bioactivity in a wide variety of biological assays.
Enzo Life Sciences CD marker antibodies
25 June, 2014Enzo Life Sciences CD marker antibodies are available to identify various features and isolate the user's target. Available in either a standard or conjugated format to a variety of detection agents, they can help researchers visualise, identify, purify and target immune cells and tissues that display CD markers on their surfaces.
Enzo Life Sciences DiSH kit for detection and production of antibodies
12 June, 2014Improving the product development cycle for new therapies is a constant challenge for drug discovery researchers. With the DiSH kit, Enzo Life Sciences provides a tool to enable rapid detection and production of highly specific monoclonal antibodies.
Patrys antibody produced in plants
03 April, 2014The IgM antibody PAT-SM6, developed by biotechnology company Patrys, has been produced through a plant-based manufacturing system.
Enzo Life Sciences high-purity native bacterial and viral antigens
05 August, 2013Enzo Life Sciences offers a broad range of native bacterial and viral antigens for the research and in vitro diagnostics markets. Wherever practical, the antigens are isolated and purified from culture. In cases where antigen yield may be very low, the antigens are produced using the latest mammalian expression systems.
Abiocode vPair Antibodies
03 May, 2013vPair antibodies from Abiocode represent a pair of fully characterised antibodies that recognise two different regions of a target protein. The product was developed to address whether the signal observed truly represents the protein of interest, an often encountered issue in antibody-based assays.
Innova Biosciences Thunder-Link oligonucleotide conjugation kits
07 March, 2013The Thunder-Link oligo conjugation system has been designed to allow the non-specialist to generate antibody oligonucelotide conjugates easily and efficiently.
Abcam RabMAbs - rabbit monoclonal antibodies
22 November, 2012Rabbit monoclonal antibodies (RabMAbs) provide the combined benefits of good antigen recognition of the rabbit immune system with the specificity and consistency of a monoclonal antibody.
MédiMabs antibodies
18 September, 2012MédiMabs provides research-grade monoclonal and polyclonal antibodies, both novel and known, for which defined affinity and purity specifications exist.
Biomedica Polyclonal Anti-human C4d antibody
17 September, 2012The Polyclonal Anti-human C4d antibody from Biomedica has been designed to identify human complement split product C4d. It is suggested to be a valuable marker for humoral rejection of kidney transplantations.
Innova Biosciences antibody purification systems
21 August, 2012Innova Biosciences has designed a range of accessory products which can be used to separate antibodies from unfavourable starting points. The kits are easy to use and are compatible with the Lightning-Link Antibody Labelling range.
ProteinTech Western blot loading control antibodies
20 August, 2012ProteinTech produces antibodies from whole protein antigens for use as Western blot loading controls.
The world’s first (official) biosimilar antibody goes to … rheumatoid arthritis
10 August, 2012On 23 July, South Korean biosimilar manufacturer Celltrion announced the approval of Remsima (CT-P13), a biosimilar antibody, by the Korean Food and Drug Administration. Remsima is a biosimilar version of Johnson & Johnson’s Remicade (infliximab), which was one of the first monoclonal antibody TNF inhibitors approved for the treatment of rheumatoid arthritis (RA).
